肺部的人类微生物群：感染是否影响肺部健康与疾病？
The Human Microbiome in the Lung: Are Infections Contributing to Lung Health and Disease?
作者信息
Gates Khalilah, Martinez Fernando
机构信息
Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Department of Medicine, Weill Cornell Medical College, Cornell University, New York, New York.
出版信息
Chronic Obstr Pulm Dis. 2016 Jan 15;3(1):466-472. doi: 10.15326/jcopdf.3.1.2015.0174.
Abstract
This article serves as a CME-available, enduring material summary of the following COPD9 presentations: "The Human Microbiome in the Lung: The Way Forward" Gary B. Huffnagle, PhD "COPD: Is it Just Bacteria?" Alison Morris, MD, MS "What We Have Learned From Other Disease States and How It Applies to COPD" Fernando Martinez, MD, MS.
摘要
本文是以下慢性阻塞性肺疾病（COPD）相关报告的可用于继续医学教育（CME）的永久性资料总结：“肺部的人类微生物组：前进之路” 加里·B·赫夫纳格尔，博士；“慢性阻塞性肺疾病：仅是细菌问题吗？” 艾莉森·莫里斯，医学博士、理学硕士；“我们从其他疾病状态中学到了什么以及如何将其应用于慢性阻塞性肺疾病” 费尔南多·马丁内斯，医学博士、理学硕士。
相似文献
1
The Human Microbiome in the Lung: Are Infections Contributing to Lung Health and Disease?肺部的人类微生物群：感染是否影响肺部健康与疾病？
Chronic Obstr Pulm Dis. 2016 Jan 15;3(1):466-472. doi: 10.15326/jcopdf.3.1.2015.0174.
2
COPD Overdiagnosis, Underdiagnosis, and Treatment.慢性阻塞性肺疾病的过度诊断、漏诊与治疗
Chronic Obstr Pulm Dis. 2016 Jan 15;3(1):491-497. doi: 10.15326/jcopdf.3.1.2015.0172.
3
Back to the Future: Past, Present, and Future is COPD360.《回到未来：过去、现在与未来》即慢性阻塞性肺疾病360。
Chronic Obstr Pulm Dis. 2016 Jan 15;3(1):473-478. doi: 10.15326/jcopdf.3.1.2015.0173.
4
Pathophysiology of Emphysema and Implications.肺气肿的病理生理学及影响
Chronic Obstr Pulm Dis. 2016 Jan 15;3(1):454-458. doi: 10.15326/jcopdf.3.1.2015.0175.
5
Interventional Options for COPD- LVRS, Bronchoscopic Therapies and the Future.慢性阻塞性肺疾病的介入治疗选择——肺减容术、支气管镜治疗及未来发展
Chronic Obstr Pulm Dis. 2016 Jan 15;3(1):446-453. doi: 10.15326/jcopdf.3.1.2015.0171.
6
Developing and Implementing Biomarkers and Novel Imaging in COPD.慢性阻塞性肺疾病中生物标志物与新型成像技术的开发与应用
Chronic Obstr Pulm Dis. 2016 Jan 15;3(1):485-490. doi: 10.15326/jcopdf.3.1.2015.0170.
7
Pulmonary Rehabilitation: Improvement with Movement.肺康复：运动带来改善。
Chronic Obstr Pulm Dis. 2016 Jan 15;3(1):479-484. doi: 10.15326/jcopdf.3.1.2015.0169.
8
COPD Overlap Syndromes: Asthma and Beyond.慢性阻塞性肺疾病重叠综合征：哮喘及其他
Chronic Obstr Pulm Dis. 2016 Jan 15;3(1):459-465. doi: 10.15326/jcopdf.3.1.2015.0176.
9
CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.继续医学教育/继续护理学教育文章：多发性硬化症的护理框架，第1部分：更新的疾病分类及特定情况下疾病修正治疗的应用
Int J MS Care. 2016 Nov-Dec;18(6):314-323. doi: 10.7224/1537-2073.2016-051.
10
Gary Huffnagle: rewriting the rules on the lung microbiome.
Lancet. 2014 Aug 23;384(9944):653. doi: 10.1016/S0140-6736(14)61382-9.
引用本文的文献
1
Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients.肺癌患者癌性肺组织与对侧非癌性肺组织中微生物群的特征分析
Front Oncol. 2020 Aug 24;10:1584. doi: 10.3389/fonc.2020.01584. eCollection 2020.
2
Autophagy markers as mediators of lung injury-implication for therapeutic intervention.自噬标志物作为肺损伤的介质-对治疗干预的影响。
Life Sci. 2020 Nov 1;260:118308. doi: 10.1016/j.lfs.2020.118308. Epub 2020 Aug 21.
本文引用的文献
1
Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中宿主对肺微生物群的反应
Am J Respir Crit Care Med. 2015 Aug 15;192(4):438-45. doi: 10.1164/rccm.201502-0223OC.
2
Spatial Variation in the Healthy Human Lung Microbiome and the Adapted Island Model of Lung Biogeography.健康人肺部微生物群的空间变异与适应性肺部生物地理学岛屿模型
Ann Am Thorac Soc. 2015 Jun;12(6):821-30. doi: 10.1513/AnnalsATS.201501-029OC.
3
Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals.健康个体上呼吸道微生物群作为肺和胃微生物群来源的分析。
mBio. 2015 Mar 3;6(2):e00037. doi: 10.1128/mBio.00037-15.
4
Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease.呼吸道真菌微生物群的地形多样性以及HIV与肺部疾病中的改变。
Am J Respir Crit Care Med. 2015 Apr 15;191(8):932-42. doi: 10.1164/rccm.201409-1583OC.
5
The role of the microbiome in exacerbations of chronic lung diseases.微生物组在慢性肺部疾病恶化中的作用。
Lancet. 2014 Aug 23;384(9944):691-702. doi: 10.1016/S0140-6736(14)61136-3.
6
Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期的气道微生物群动态变化
J Clin Microbiol. 2014 Aug;52(8):2813-23. doi: 10.1128/JCM.00035-14. Epub 2014 May 21.
7
Lung microbiome for clinicians. New discoveries about bugs in healthy and diseased lungs.临床医生的肺部微生物群。关于健康和患病肺部微生物的新发现。
Ann Am Thorac Soc. 2014 Jan;11(1):108-16. doi: 10.1513/AnnalsATS.201310-339FR.
8
The cystic fibrosis lung microbiome.囊性纤维化肺部微生物群。
Ann Am Thorac Soc. 2014 Jan;11 Suppl 1:S61-5. doi: 10.1513/AnnalsATS.201306-159MG.
9
Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.病毒感染后慢性阻塞性肺疾病气道微生物组的衍生。
Am J Respir Crit Care Med. 2013 Nov 15;188(10):1224-31. doi: 10.1164/rccm.201302-0341OC.
10
The role of the bacterial microbiome in lung disease.细菌微生物组在肺部疾病中的作用。
Expert Rev Respir Med. 2013 Jun;7(3):245-57. doi: 10.1586/ers.13.24.
Zotero 插件